| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.36B | +15.0% |
| Cost of Revenue | $946.3M | +19.9% |
| Gross Profit | $409.3M | +5.0% |
| R&D Expense | $9.5M | +28.4% |
| SG&A Expense | $279.9M | +14.6% |
| Operating Income | $128.9M | -9.3% |
| Interest Expense | $25.0M | +22.9% |
| Pre-tax Income | $104.0M | -14.6% |
| Income Tax | $28.8M | +0.3% |
| Net Income | $75.2M | -19.2% |
| EPS (Basic) | $0.49 | -19.7% |
| EPS (Diluted) | $0.49 | -16.9% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.8M | -51.8% |
| Accounts Receivable | $90.2M | +16.6% |
| Inventory | $299.9M | +58.8% |
| Current Assets | $530.6M | -0.3% |
| Total Assets | $2.38B | +8.9% |
| Current Liabilities | $182.5M | +7.1% |
| Long-term Debt | $600.0M | +29.1% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $105.8M | -49.0% |
| Capital Expenditures | $170.9M | -2.4% |
| Investing Cash Flow | -$280.2M | -60.0% |
| Financing Cash Flow | $44.6M | +1429.2% |
| Free Cash Flow | -$65.1M | -299.9% |
| Total Liabilities |
| $938.6M |
| +23.4% |
| Stockholders' Equity | $1.44B | +1.2% |